Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation

Area of Science:

• Hematology
• Oncology
• Biochemistry

Background:

• Tissue factor (TF)-bearing microparticles (MP) are implicated in cancer-associated thrombosis.
• The specific role of circulating tumor cell-derived TF in this process remains unclear.

Purpose of the Study:

• To investigate the procoagulant activity (PCA) of TF in microparticles derived from human cancer cells.
• To determine the in vivo effects and clearance mechanisms of these tumor cell-derived microparticles (TMP).

Main Methods:

• TF antigen and activity were measured in vitro using ELISA and clotting assays.
• In vivo studies involved injecting TMP into mice and analyzing cell-free plasmas and spleen tissues.
• Coagulation activation was assessed by measuring TF-dependent PCA and thrombin-antithrombin complexes.

Main Results:

• Tumor cell-derived MP (TMP) demonstrated significant TF-dependent PCA both in vitro and in vivo.
• TMP injection induced thrombocytopenia and shock-like symptoms in mice, preventable with heparin.
• The spleen was identified as a key organ for the rapid clearance of circulating MP.

Conclusions:

• Cancer cell-derived MP possess TF-dependent PCA, contributing to hypercoagulability in cancer patients.
• These findings elucidate the specific role of tumor-derived MP in cancer-associated thrombosis.